Afrezza and Acute bronchospasm
Result of checking the interaction of drug Afrezza and disease Acute bronchospasm for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of inhaled insulin is contraindicated in patients with chronic lung disease such as asthma and COPD. Acute bronchospasm has been observed after an inhaled insulin dosage. Prior to initiating therapy with an inhaled insulin product, it is recommended to evaluate all patients medical history, physical examination and spirometry (FEV1) to identify potential underlying lung disease.
Generic Name: insulin inhalation, rapid acting
Brand Name: Afrezza, Exubera, Exubera, EXUBERA Combination Pack 12, EXUBERA Combination Pack 15, EXUBERA Kit, Afrezza 4 unit- 8 unit, Afrezza 8 unit- 12 unit, Afrezza Titration Pack
Synonyms: n.a.